Preoperative Oral Carbohydrate Drink for Elective Cesarean Delivery and the Effect on Insulin Sensitivity
Sponsor: Mayo Clinic
Terminated
need additional funding
This NA trial investigates Insulin Sensitivity and is currently terminated or withdrawn. Mayo Clinic leads this study, which shows 16 recorded versions since 2019 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
16 versions recorded-
Jun 2025 — Present [monthly]
Terminated NA
Status: Suspended → Terminated
-
Sep 2024 — Jun 2025 [monthly]
Suspended NA
-
Jul 2024 — Sep 2024 [monthly]
Suspended NA
-
May 2024 — Jul 2024 [monthly]
Suspended NA
-
May 2023 — May 2024 [monthly]
Suspended NA
▶ Show 11 earlier versions
-
May 2022 — May 2023 [monthly]
Suspended NA
-
May 2021 — May 2022 [monthly]
Suspended NA
Status: Enrolling By Invitation → Suspended
-
Jan 2021 — May 2021 [monthly]
Enrolling By Invitation NA
-
Aug 2020 — Jan 2021 [monthly]
Enrolling By Invitation NA
-
May 2020 — Aug 2020 [monthly]
Enrolling By Invitation NA
-
May 2019 — May 2020 [monthly]
Enrolling By Invitation NA
-
Mar 2019 — May 2019 [monthly]
Enrolling By Invitation NA
-
Feb 2019 — Mar 2019 [monthly]
Enrolling By Invitation NA
-
Dec 2018 — Feb 2019 [monthly]
Enrolling By Invitation NA
-
Jul 2018 — Dec 2018 [monthly]
Enrolling By Invitation NA
-
May 2018 — Jul 2018 [monthly]
Enrolling By Invitation NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Mayo Clinic
For direct contact, visit the study record on ClinicalTrials.gov .